OIA
SURF

Optimum Investment Advisors’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Optimum Investment Advisors’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,000
Closed -$28K – 974
2020
Q4 		$28K Buy
+3,000
New +$26.1K 0.01% 575

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Optimum Investment Advisors's SURF Position: Q1 2021 in Review

Optimum Investment Advisors sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2021, closing a stake of 3,000 shares — an estimated $28K sold.

Optimum Investment Advisors first reported a position in SURF in Q4 2020 and held it in 1 quarter. The position peaked at $28K in Q4 2020. 90 funds tracked by Wall St. Rank hold SURF as of Q1 2021.

  • Optimum Investment Advisors reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Optimum Investment Advisors sold 3,000 Surface Oncology, Inc. Common Stock shares in Q1 2021, an estimated $28K.
  • Optimum Investment Advisors first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Optimum Investment Advisors's Surface Oncology, Inc. Common Stock position peaked at $28K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2021.

Based on Optimum Investment Advisors's 13F filing for Q1 2021, filed 15 Apr 2021.